Liposomal antifungals battle for market share

摘要

ALLENTOWN, Penn.--Oddly enough, all three U.S.. biopharm-aceutical firms developing liposo-mal pharmaceuticals.have reached the European market with their iead products. Al! three of these products are antifungai agents. And all three are currently battling for market share. The three firms are NeXstar Pharmaceuticals (Boulder, CO), Sequus Pharmaceuticals (Menlo Park, CA)--which, until recently, was known as Liposome Technology- and The Liposome Company (TLC, Princeton, NJ).